Cancer cells in state 3, which positively responded to NAT, exhibited significantly elevated expression levels of immune-related genes, including those implicated in neutrophil activation, antigen processing and presentation, and response to IFNγ (Fig. 2F). This evidence concerns the gene BRD2 and cancer.